PDRX.US Pd-Rx Pharmaceutical

Healthcare Health Care Providers & Services USA Stocks
3.35 USD
Close of Nov 15, 2026
2.80 3.35
Market cap
USD 5.75M
P/E
2.9x
P/B
-
ROE
-2.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2025.

Is PDRX.US undervalued?

Graham number

The Graham number of Pd-Rx Pharmaceutical cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pd-Rx Pharmaceutical fundamental analysis

No fundamental analysis for Pd-Rx Pharmaceutical yet.

Pd-Rx Pharmaceutical stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pd-Rx Pharmaceutical

PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, such as creams, ointments, ophthalmics, otics, liquids, and suspension products. It also provides packaging services. In addition, the company offers a dispensing platform, a manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as a ha…

Full company profile